Literature DB >> 18629586

Evaluation of supplemental cautery during endoluminal gastroplication for the treatment of gastroesophageal reflux disease.

Patrick Mosler1, Ayman M Abdel Aziz, Karen Hieston, Charles Filipi, Glen Lehman.   

Abstract

BACKGROUND: Endoscopic suture plications at the cardia decreased gastroesophageal reflux disease (GERD) symptoms in short-term studies. Pull-through of submucosal sutures may lead to loss of efficacy. The application of cautery on mucosal surfaces may promote tissue adherence. This study aimed to compare the efficacy of endoluminal gastroplication (ELGP) using Endocinch with and without adjuvant cautery.
METHODS: Vertical plications were created using ELGP. Patients were randomized to either ELGP alone or ELGP with an adjuvant bicap cautery. Patients were blinded to their randomization category and encouraged to take antisecretory medications if needed. Heartburn was scored on a scale of 0 (none), 1 (occasional), 2 (frequent), or 3 (daily). Patients undergoing a second antireflux procedure during the follow-up period were considered study failures and scored 3.
RESULTS: Of the 18 patients enrolled in the study, 1 was lost to follow-up evaluation at 12 months and 2 could not be followed up at 24 months. The cautery group included 10 patients (9 men) with a mean age of 53.2 years. The group without cautery consisted of 8 patients (5 men) with a mean age of 50.4 years. The use of ELGP with cautery resulted in a trend toward greater improvement in several parameters (heartburn score, total percentage of time that pH was less than 4, and medication use) at 12 months than ELGP without cautery. These trends were not seen at 24 months, when all but 1 patient had ongoing symptoms, used daily proton pump inhibitor/H2-blocker, or went on to undergo a second antireflux procedure (2 Nissen and 3 Enteryx).
CONCLUSIONS: Cautery numerically improved plication persistence, decreased esophageal acid exposure, and improved symptoms at 1 year compared with sutures alone. Little or no long-term efficacy of ELGP with or without cautery was observed after 2 years of follow-up evaluation.

Entities:  

Mesh:

Year:  2008        PMID: 18629586     DOI: 10.1007/s00464-008-0011-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  10 in total

1.  Transoral, flexible endoscopic suturing for treatment of GERD: a multicenter trial.

Authors:  C J Filipi; G A Lehman; R I Rothstein; I Raijman; G V Stiegmann; J P Waring; J G Hunter; C J Gostout; S A Edmundowicz; D P Dunne; P A Watson; D A Cornet
Journal:  Gastrointest Endosc       Date:  2001-04       Impact factor: 9.427

2.  Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plications.

Authors:  Arnaldo B Feitoza; Christopher J Gostout; Elizabeth Rajan; Rory L Smoot; Lawrence J Burgart; Cathy Schleck; Alan R Zinsmeister
Journal:  Gastrointest Endosc       Date:  2003-06       Impact factor: 9.427

Review 3.  GERD pathogenesis, pathophysiology, and clinical manifestations.

Authors:  Peter J Kahrilas
Journal:  Cleve Clin J Med       Date:  2003-11       Impact factor: 2.321

4.  Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.

Authors:  Kenneth R DeVault; Donald O Castell
Journal:  Am J Gastroenterol       Date:  2005-01       Impact factor: 10.864

5.  Long-term failure of endoscopic suturing in the treatment of gastroesophageal reflux: a prospective follow-up study.

Authors:  H Abou-Rebyeh; N Hoepffner; T Rösch; E Osmanoglou; J H Haneke; R E Hintze; B Wiedenmann; H Mönnikes
Journal:  Endoscopy       Date:  2005-03       Impact factor: 10.093

6.  Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial.

Authors:  M P Schwartz; H Wellink; H G Gooszen; J M Conchillo; M Samsom; A J P M Smout
Journal:  Gut       Date:  2006-06-08       Impact factor: 23.059

7.  Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A randomized, sham-controlled trial.

Authors:  Richard Rothstein; Charles Filipi; Karel Caca; Ronald Pruitt; Klaus Mergener; Alfonso Torquati; Gregory Haber; Yang Chen; Kenneth Chang; David Wong; Jacques Deviere; Douglas Pleskow; Charles Lightdale; Alain Ades; Richard Kozarek; William Richards; Anthony Lembo
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

Review 8.  Laparoscopic antireflux surgery.

Authors:  B Y Safadi
Journal:  Minerva Chir       Date:  2004-10       Impact factor: 1.000

Review 9.  Gastroesophageal reflux disease: then and now.

Authors:  Irvin M Modlin; Steven F Moss; Mark Kidd; Kevin D Lye
Journal:  J Clin Gastroenterol       Date:  2004 May-Jun       Impact factor: 3.062

10.  Natural history of gastro-oesophageal reflux disease diagnosed in general practice.

Authors:  A Ruigómez; L A García Rodríguez; M-A Wallander; S Johansson; H Graffner; J Dent
Journal:  Aliment Pharmacol Ther       Date:  2004-10-01       Impact factor: 8.171

  10 in total
  3 in total

1.  Four-year follow-up of endoscopic gastroplication for the treatment of gastroesophageal reflux disease.

Authors:  Matthijs P Schwartz; J Rieneke C Schreinemakers; André J P M Smout
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

Review 2.  Endoscopic therapies of gastroesophageal reflux disease.

Authors:  Atif Iqbal; Vanessa Salinas; Charles-J Filipi
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

3.  Antireflux endoluminal therapies: past and present.

Authors:  Kuo Chao Yew; Seng-Kee Chuah
Journal:  Gastroenterol Res Pract       Date:  2013-07-09       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.